J W Rasenack

Summary

Affiliation: University of Freiburg
Country: Germany

Publications

  1. ncbi request reprint [Hepatitis C--standard therapy]
    J W Rasenack
    Abteilung für Gastroenterologie, Hepatologie und Endokrinolologie, Medizinische Universitatsklinik Freiburg
    Praxis (Bern 1994) 89:1049-55. 2000
  2. ncbi request reprint Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C
    Jens Rasenack
    Klinikum der Albert Ludwigs Universität, Freiburg, Germany
    Pharmacoeconomics 21:341-9. 2003

Detail Information

Publications2

  1. ncbi request reprint [Hepatitis C--standard therapy]
    J W Rasenack
    Abteilung für Gastroenterologie, Hepatologie und Endokrinolologie, Medizinische Universitatsklinik Freiburg
    Praxis (Bern 1994) 89:1049-55. 2000
    ....
  2. ncbi request reprint Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C
    Jens Rasenack
    Klinikum der Albert Ludwigs Universität, Freiburg, Germany
    Pharmacoeconomics 21:341-9. 2003
    ..Treatment with peginterferon alpha-2a (40kD) provides an improved sustained response over unmodified interferon alpha-2a...